Biotech | November 18, 2022
Strand Life Sciences launches ‘Strand Genomic Wellness’
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
The company is focussed on increasing the capacity utilizations while controlling costs
First PARP inhibitor to demonstrate clinical benefit in radiographic progression-free survival in combination with a new hormonal agent with or without homologous recombination repair gene mutations
Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers
Reinforcing GLC’s commitment to sustainable processing in pharmaceutical chemistry
This is the fifth consecutive year that a Biocon Group company has made it to the Asia lP ELITE list
Formulation revenue decreased by 7.6% YoY to Rs. 4,770 crore whereas in Q2 FY23, API business posted a growth of 24.2% YoY with revenue of Rs. 969.4 crore
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
